ANP 32E induces tumorigenesis of triple‐negative breast cancer cells by upregulating E2F1-Reference-Cited by-同舟云学术

ANP 32E induces tumorigenesis of triple‐negative breast cancer cells by upregulating E2F1

Published:2018-04-18 Issue:6 Volume:12 Page:896-912
ISSN:1574-7891
Container-title:Molecular Oncology
language:en
Short-container-title:Mol Oncol

Author:

Xiong Zhenchong¹^ORCID,Ye Liping²,Zhenyu He³^ORCID,Li Fengyan³,Xiong Yahui⁴,Lin Chuyong²,Wu Xianqiu²,Deng Guangzheng¹,Shi Wei⁵,Song Libing²,Yuan Zhongyu⁵,Wang Xi¹

Affiliation:

1. Department of Breast Surgery State Key Laboratory of Oncology in Southern China Collaborative Innovation Center for Cancer Medicine Sun Yat‐sen University Cancer Center Guangzhou China

2. Department of Experimental Research State Key Laboratory of Oncology in Southern China Collaborative Innovation Center for Cancer Medicine Sun Yat‐sen University Cancer Center Guangzhou China

3. Department of Radiation Oncology State Key Laboratory of Oncology in Southern China Collaborative Innovation Center for Cancer Medicine Sun Yat‐sen University Cancer Center Guangzhou China

4. The First College of Clinical Medicine Southern Medical University Guangzhou China

5. Department of Medical Oncology State Key Laboratory of Oncology in Southern China Collaborative Innovation Center for Cancer Medicine Sun Yat‐sen University Cancer Center Guangzhou China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cancer Research,Genetics,Molecular Medicine,General Medicine,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/1878-0261.12202

Reference50 articles.

1. Locoregional treatment versus no treatment of the primary tumour in metastatic breast cancer: an open-label randomised controlled trial

2. DEC1 regulates breast cancer cell proliferation by stabilizing cyclin E protein and delays the progression of cell cycle S phase

3. Identification of pathways regulating cell size and cell-cycle progression by RNAi